Affinity Biopharma is a global, clinical stage biopharmaceutical company focused on advancing innovative technology and first-in-class anti-tumor treatment. We have established our Tumor MicroEnvironment Activated (TMEA) platform technology including TMEA-SMDC, TMEAbody®, TMEAkine®, TMEA-ICE®, ADC and TMEA-XDC platforms.
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar companies
Tired of ads? Enjoy an ad-free experience by signing up.